Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.944
-0.033 (-3.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.959
+0.015 (1.63%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Quince Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Quince Therapeutics stock have an average target of 4.00, which predicts an increase of 323.95% from the current stock price of 0.94.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quince Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 1 | 0 | 0 | 2 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 0 | 0 |
| Total | 6 | 6 | 6 | 4 | 3 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $4 | Buy | Initiates | $4 | +323.95% | Jun 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $4 | Buy | Initiates | $4 | +323.95% | Jun 23, 2026 |
| Maxim Group | Maxim Group | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Feb 2, 2026 |
| Lucid Capital | Lucid Capital | Sell Downgrades n/a | Sell | Downgrades | n/a | n/a | Jan 30, 2026 |
| D. Boral Capital | D. Boral Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jan 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.79M
EPS This Year
-0.27
from -16.80
EPS Next Year
-1.31
from -0.27
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 51.2M | |
| Avg | n/a | 12.8M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 700.8% |
| Avg | - | 100.2% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.10 | -0.33 | |
| Avg | -0.27 | -1.31 | |
| Low | -0.43 | -2.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.